That's my perspective. Regulators are heavily incentivized to prevent deaths, even small numbers, that will generate headlines and political pressure. There is no political voice for much larger numbers that would be aided by new drugs that come to market quicker in a looser regulatory scheme.

That said, I understand why the laws have been shaped the way they have.